These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27940005)

  • 21. [Validation of a questionnaire assessing patients' adherence and skill level of management for oral capecitabine treatment].
    Baudot A; Oriol M; Tinquaut F; Moine V; Moriceau G; Muron T; Pacaut C; Collard O; Jacquin JP; Saban-Roche L; Bosacki C; Regnier-Denois V; Chauvin F; Bourmaud A
    Bull Cancer; 2016 Mar; 103(3):241-51. PubMed ID: 26917467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiotoxicity induced by 5-fluorouracil or capecitabine].
    Jensen SA; Baeksgaard L; Petersen LN; Reiter L; Sørensen JB
    Ugeskr Laeger; 2010 Jan; 172(1):48-51. PubMed ID: 20056096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capecitabine-induced pancreatitits.
    Cornejo-Uixeda S; Escoin-Pérez C; Hernandez-Lorente E
    Med Clin (Barc); 2018 Jun; 150(11):e37-e38. PubMed ID: 29150119
    [No Abstract]   [Full Text] [Related]  

  • 24. Capecitabine for treating head and neck cancer.
    Iqbal H; Pan Q
    Expert Opin Investig Drugs; 2016 Jul; 25(7):851-9. PubMed ID: 27144283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery.
    Zhao Y; Korolj A; Feric N; Radisic M
    Expert Opin Drug Saf; 2016 Nov; 15(11):1455-1458. PubMed ID: 27560951
    [No Abstract]   [Full Text] [Related]  

  • 26. Oromandibular dystonia: a serious side effect of capecitabine.
    van Pelt-Sprangers MJ; Geijteman EC; Alsma J; Boere IA; Mathijssen RH; Schuit SC
    BMC Cancer; 2015 Mar; 15():115. PubMed ID: 25850956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Capecitabine in breast cancer: the issue of cardiotoxicity during fluoropyrimidine treatment.
    Molteni LP; Rampinelli I; Cergnul M; Scaglietti U; Paino AM; Noonan DM; Bucci EO; Gottardi O; Albini A
    Breast J; 2010; 16 Suppl 1():S45-8. PubMed ID: 21050310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.
    He Y; Liu P; Zhang Y; Deng X; Meng W; Wei M; Yang T; Wang Z; Qiu M
    Trials; 2015 May; 16():238. PubMed ID: 26021722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Capecitabine in locally advanced anal cancer, do we need randomised evidence?
    Chong LC; Healey T; Michele T; Price TJ
    Expert Rev Anticancer Ther; 2017 May; 17(5):411-416. PubMed ID: 28277833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capecitabine: toxic encephalopathy.
    Prescrire Int; 2015 Nov; 24(165):269. PubMed ID: 26688902
    [No Abstract]   [Full Text] [Related]  

  • 31. Fixed Drug Eruption Late in the Course of Capecitabine Therapy.
    Del Rosario M; Tsai H; Dasanu CA
    Conn Med; 2016 Apr; 80(4):223-5. PubMed ID: 27265926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
    Bourmaud A; Henin E; Tinquaut F; Regnier V; Hamant C; Colomban O; You B; Ranchon F; Guitton J; Girard P; Freyer G; Tod M; Rioufol C; Trillet-Lenoir V; Chauvin F
    BMC Res Notes; 2015 Jul; 8():291. PubMed ID: 26142140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study.
    Akgun Z; Saglam S; Yucel S; Gural Z; Balik E; Cipe G; Yildiz S; Kilickap S; Okyar A; Kaytan-Saglam E
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):751-6. PubMed ID: 25102935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer.
    Lu NN; Jin J; Wang SL; Wang WH; Song YW; Liu YP; Ren H; Fang H; Liu XF; Yu ZH; Li YX
    PLoS One; 2015; 10(4):e0124601. PubMed ID: 25915948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of Durable Responder for Capecitabine Monotherapy in Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer.
    Hong JY; Park YH; Choi MK; Jung HA; Lee SJ; Ahn JS; Im YH
    Clin Breast Cancer; 2015 Oct; 15(5):e287-92. PubMed ID: 25997855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capecitabine-induced Leukoencephalopathy.
    Yoshimura K; Tokunaga S; Daga H; Inoue M
    Intern Med; 2019 Feb; 58(4):621-622. PubMed ID: 30333392
    [No Abstract]   [Full Text] [Related]  

  • 38. Capecitabine, a possible reason of sudden cardiac death.
    Ridruejo R; Gonzalez C; Jorge R
    Med Clin (Barc); 2017 Feb; 148(3):143-144. PubMed ID: 27939916
    [No Abstract]   [Full Text] [Related]  

  • 39. Capecitabine leukoencephalopathy.
    Yasiry Z; Obeda MS; Batty R; Sharrack B
    Pract Neurol; 2019 Jun; 19(3):270-271. PubMed ID: 30612099
    [No Abstract]   [Full Text] [Related]  

  • 40. Capecitabine and adermatoglyphia: trouble in border!
    Mazza C; Slimano F; Visseaux L; Ordan MA; Botsen D; Grange F; Bouche O
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e283-e284. PubMed ID: 27859657
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.